131 related articles for article (PubMed ID: 8801814)
1. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx.
Zhao R; Hirano M; Kurita S
Am J Otolaryngol; 1996; 17(1):36-44. PubMed ID: 8801814
[TBL] [Abstract][Full Text] [Related]
2. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
Zidar N; Gale N; Cör A; Kambic V
J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
[TBL] [Abstract][Full Text] [Related]
3. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
4. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
Zhou G; Lin D; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
6. PCNA--a cell proliferation marker in vocal chord cancer. Part I: Premalignant laryngeal lesions.
Pignataro LD; Broich G; Lavezzi AM; Biondo B; Ottaviani F
Anticancer Res; 1995; 15(4):1517-20. PubMed ID: 7654040
[TBL] [Abstract][Full Text] [Related]
7. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
8. [The meaning of the expression of PCNA and c-erbB-2 in the hyperplasia of laryngeal epithelium].
Yao Q; Lu X; Huang Z; Cao Y; Jiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):263-4. PubMed ID: 12563981
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
[TBL] [Abstract][Full Text] [Related]
10. [Precancerous states of the larynx: analysis of mono- and polyclonality of the cells with high proliferative index (p53, PCNA)].
Gabriel A; Namysłowski G; Drozdzowska B; Morawski K; Steplewska-Mazur K; Gwóźdź M
Otolaryngol Pol; 2000; 54 Suppl 31():178-81. PubMed ID: 10974878
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between tumor cell proliferating activity and biological behavior, prognosis in laryngeal carcinoma].
Zhou G; Liang C; Lin D; Zhang X; Wen D; Liu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):178-81. PubMed ID: 10684010
[TBL] [Abstract][Full Text] [Related]
13. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
14. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
Broich G; Lavezzi AM; Biondo B; Pignataro LD
In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
Kram A; Domagała W
Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szkudlarek T; Jeleń-Krzeszewska J
Oral Oncol; 1999 Mar; 35(2):180-6. PubMed ID: 10435153
[TBL] [Abstract][Full Text] [Related]
17. Expression of the extracellular matrix protein tenascin in laryngeal epithelial lesions: correlation with fibronectin, CD44, cathepsin D and proliferation indices.
Goussia AC; Ioachim EE; Peschos D; Assimakopoulos DA; Skevas A; Agnantis NJ
Virchows Arch; 2000 Jun; 436(6):579-84. PubMed ID: 10917172
[TBL] [Abstract][Full Text] [Related]
18. Automated image analysis of proliferating cells in carcinoma of the larynx.
Laitakari J; Harrison D; Stenbäck F
Acta Otolaryngol; 2003 Aug; 123(6):759-66. PubMed ID: 12953780
[TBL] [Abstract][Full Text] [Related]
19. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
20. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]